Ross, J., Fakih, M., Ali, S., Elvin, J., Schrock, A., Suh, J., … Gay, L. (2018). Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer. https://doi.org/10.1002/cncr.31125 (Original work published 2018)

Egilman, A., Wallach, J., Ross, J., & Dhruva, S. (2018). Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2017.8016 (Original work published 2018)

Charalel, R., Durack, J., Mao, J., Ross, J., Meltzer, A., & Sedrakyan, A. (2018). Statewide Inferior Vena Cava Filter Placement, Complications, and Retrievals: Epidemiology and Recent Trends. Medical Care. https://doi.org/10.1097/MLR.0000000000000867 (Original work published 2018)

Schrock, A., Pavlick, D., Klempner, S., Chung, J., Forcier, B., … Welsh, A. (2018). Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-17-3103 (Original work published 2018)

Lin, J., Zhu, V., Yoda, S., Yeap, B., Schrock, A., Dagogo-Jack, I., … Ou, S. (2018). Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, JCO2017762294. https://doi.org/10.1200/JCO.2017.76.2294 (Original work published 2018)

Ross, J., & Krumholz, H. (2018). Bringing Vioxx back to market. BMJ (Clinical Research Ed.), 360, k242. (Original work published 2018)